GlassScriptPhysician profile
Natalie Alexandra Marks
NPI 1942528724
$22,772.96
in general payments reported to CMS, 2019-2025
6 companies · $3,393 in 2025
The $3,393 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.87 · 2020: $15.89 · 2021: $3,237 · 2022: $6,577 · 2023: $6,332 · 2024: $3,200 · 2025: $3,393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $9,600 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,100 · Food and Beverage: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $9,600.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,100.00 |
| Food and Beverage | $225.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $16,013.02 | 2021-2025 | Venacure 1470 Pro |
| Advanced Oxygen Therapy INC. | $6,343.09 | 2021-2023 | Topical Oxygen Chamber For Extremities |
| Boston Scientific Corporation | $207.59 | 2019-2023 | Opticross 35 |
| W. L. Gore & Associates, INC. | $172.58 | 2025 | Gore Viabahn Endoprosthesis With Heparin |
| Tactile Systems Technology INC | $20.79 | 2025 | Nimbl, Flexitouch Plus |
| Venclose INC. | $15.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Marks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.